Rigel Pharmaceuticals Inc. (RIGL)

3.70
NASDAQ : Health Technology
Prev Close 3.70
Day Low/High 0.00 / 0.00
52 Wk Low/High 2.14 / 4.71
Avg Volume 1.38M
Exchange NASDAQ
Shares Outstanding 144.65M
Market Cap 559.81M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Rigel Announces Departure Of Chief Financial Officer

Rigel Announces Departure Of Chief Financial Officer

Launches Search for Chief Financial Officer with Commercial-Stage Expertise

Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 20% Using Options

Investors considering a purchase of Rigel Pharmaceuticals Inc shares, but tentative about paying the going market price of $3.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $2.50 strike, which has a bid at the time of this writing of 50 cents.

Dimension Shares Rise On Sale to Ultragenyx - Biotech Movers

Dimension Shares Rise On Sale to Ultragenyx - Biotech Movers

Dimension Therapeutics said Oct. 3 it has agreed to sell to Ultragenyx Pharmaceutical for $6 a share in cash or about $151M.

Rigel Rises on Update on FDA Review of Bleeding Disorder Treatment

Rigel Rises on Update on FDA Review of Bleeding Disorder Treatment

The South San Francisco, Calif.-based firm said the U.S. Food and Drug Administration indicated that it does not plan to conduct an Oncology Drugs Advisory Committee meeting to discuss Rigel's new drug application for fostamatinib in chronic or persistent immune thrombocytopenia.

Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers

Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers

Otonomy shares rose in premarket trading on Aug. 31 after plunging Wednesday on the heels of disappointing data in a Phase 3 study of Otividex in patients with Meniere's disease.

Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 30.6% Annualized Using Options

Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 30.6% Annualized Using Options

Investors considering a purchase of Rigel Pharmaceuticals Inc shares, but tentative about paying the going market price of $2.85/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2018 put at the $2.50 strike, which has a bid at the time of this writing of 55 cents.

Biotech Movers: Clovis, Seattle Genetics, Rigel

Biotech Movers: Clovis, Seattle Genetics, Rigel

Clovis Oncology, Seattle Genetics and Rigel Pharmaceuticals were among the biotech stock movers in premarket trading on June 19.

Arena Takes a Beating After Lackluster Secondary, Cytokinetics Pops: Biotech Movers

Arena Takes a Beating After Lackluster Secondary, Cytokinetics Pops: Biotech Movers

Arena Pharmaceuticals, Rigel Pharmaceuticals and Cytokinetics were among the biotech stock movers in premarket trading on Tuesday.

Immunomedics, Mylan Lead Biotech Movers

Immunomedics, Mylan Lead Biotech Movers

Investors weren't completely distracted by the Affordable Care Act debate.

TheStreet Quant Rating: D (Sell)